General Health
September 13, 2024
Apixaban, Approved by the FDA in 2012, Eliquis has become a widely recognized anticoagulant used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). Eliquis is available in tablet form, offering a convenient and effective oral anticoagulation therapy. Known for its targeted inhibition of Factor Xa, Eliquis helps prevent the formation of harmful blood clots. The brand emphasizes adherence to prescribed dosages and monitoring for potential side effects to ensure safe and effective treatment.
